Spectrum Pharmaceuticals, Inc (NASDAQ:SPPI) has lately been going through difficult times. The most tragic point was when the biopharma pronounced the failure of the drugs in the Phase II trial. These had been targeted towards the treatment of very severe lung cancer. The test confirmed that the drug did not meet the required endpoint, something […]
Sign Up To Get Our Instant Alerts!
- Japanese Premier Declares COVID-19 State of Emergency in Tokyo 477 views
- JPMorgan Bringing Back Employees to Work From Office 453 views
- Ferari Poaches New CEO From Tech Industry 438 views
- China Unveils Maglev Train With a Top Speed of 600 kph 370 views
- Apple Employee Claims to Have Been Dismissed After Leading Movement Against Harassment 341 views